Previous studies have revealed that FBXL6 is upregulated in many types of human cancers, such as CRC [19], renal cell carcinoma [37], and gastric cancer [38], and that FBXL6 upregulation contributes to tumorigenesis and cancer development. Here, FBXL6 is linked to hereditary clear cell renal cell carcinoma.